-
Viridian Therapeutics (NASDAQ:VRDN) priced an underwritten public offering of shares, selling a total of ~11.43M shares at $22.00 per share.
-
The underwriters have a 30-day option to purchase an additional ~1.71M shares.
-
The gross proceeds to Viridian are expected to
Viridian Therapeutics prices $251M share offering (VRDN:NASDAQ)

